Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
242
NMPA:242
Drug Approvals
Epinephrine Hydrochloride Injection
- Product Name
- 盐酸肾上腺素注射液
- Approval Number
- 国药准字H20253992
- Approval Date
- Apr 22, 2025
NMPA
Neostigmine Methylsulfate Injection
- Product Name
- 甲硫酸新斯的明注射液
- Approval Number
- 国药准字H20249320
- Approval Date
- Nov 15, 2024
NMPA
Riboflavin Sodium Phosphate Injection
- Product Name
- 核黄素磷酸钠注射液
- Approval Number
- 国药准字H20093989
- Approval Date
- Jun 7, 2024
NMPA
Riboflavin Sodium Phosphate Injection
- Product Name
- 核黄素磷酸钠注射液
- Approval Number
- 国药准字H20093990
- Approval Date
- Jun 7, 2024
NMPA
Metaraminol Bitartrate Injection
- Product Name
- 重酒石酸间羟胺注射液
- Approval Number
- 国药准字H20243727
- Approval Date
- May 15, 2024
NMPA
Colloidal Bismuth Tartrate
- Product Name
- 胶体酒石酸铋
- Approval Number
- 国药准字H20093554
- Approval Date
- Feb 6, 2024
NMPA
Flucloxacillin Sodium for Injection
- Product Name
- 伊芬
- Approval Number
- 国药准字H20080369
- Approval Date
- May 22, 2023
NMPA
Sodium Fusidate for Injection
- Product Name
- 注射用夫西地酸钠
- Approval Number
- 国药准字H20084207
- Approval Date
- May 22, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 25
- Next
Clinical Trials
No trials found
News
No news found